backgroundth
data
human
rhinoviru
hrv
coronaviru
hcov
bocaviru
hbov
metapneumoviru
hmpv
chlamydophila
pneumonia
mycoplasma
pneumonia
bordetella
pertussi
infect
children
cancer
limit
methodsw
sought
determin
prospect
preval
respiratori
pathogen
children
use
multiplexedpcr
resultsw
enrol
children
upper
lower
respiratori
tract
infect
urtilrti
one
year
period
respiratori
viru
detect
patient
patient
urti
human
rhinoviru
common
viru
detect
patient
urti
lrti
respect
leukemia
lymphoma
common
underli
diagnosi
patient
follow
solid
tumor
posthematopoiet
stem
cell
transplant
hct
brain
tumor
patient
multipl
logist
regress
analysi
hbov
commonli
detect
respiratori
viru
patient
lrti
p
odd
ratio
confid
interv
coinfect
viru
present
patient
increas
risk
lrti
two
patient
succumb
lrti
parainfluenza
viru
piv
respiratori
syncyti
virushrv
infect
respect
cpneumonia
mpneumonia
detect
patient
respect
conclusionshrv
common
viru
detect
children
cancer
posthct
hospit
acut
respiratori
ill
associ
increas
morbid
prospect
studi
viral
load
determin
asymptomat
control
need
studi
associ
emerg
respiratori
virus
lrti
children
cancer
posthct
aliquot
sampl
remain
complet
clinic
diagnost
test
aliquot
test
multiplexedpcr
previous
describ
remov
patient
identifi
physician
blind
result
test
aliquot
test
aliquot
perform
use
autom
broadli
multiplex
pcrsystem
filmarray
idaho
technolog
inc
salt
lake
citi
ut
integr
specimen
process
nest
multiplexedpcr
system
enabl
simultan
detect
hrv
hbov
human
enteroviru
piv
rsv
influenza
influenza
influenza
influenza
influenza
b
human
adenoviru
hmpv
pneumonia
c
pneumonia
b
pertussi
day
infect
onset
defin
day
first
posit
sampl
collect
patient
consid
infect
respiratori
viru
detect
multiplexedpcr
urti
defin
presenc
follow
symptom
fever
rhinorrhea
nasal
congest
otiti
media
pharyng
cough
normal
chest
examin
chest
radiograph
lrti
includ
suggest
symptom
sign
crepit
rhonchi
lung
auscult
new
pulmonari
infiltr
seen
radiographi
durat
viral
shed
time
day
first
posit
first
neg
test
result
mortal
consid
attribut
respiratori
viru
patient
die
lrti
result
respiratori
failur
detect
viru
respiratori
sampl
ascertain
caus
clinic
data
abstract
prospect
collect
databas
includ
patient
demograph
underli
diseas
urtilrti
use
system
steroid
week
infect
radiolog
find
copathogen
presenc
fever
need
oxygen
mechan
ventil
admiss
intens
care
unit
mortal
absolut
neutrophil
count
anc
absolut
lymphocyt
count
alc
time
infect
descript
statist
cohort
preval
respiratori
virus
patient
urtilrti
provid
fischer
exact
test
test
use
compar
preval
respiratori
virus
age
gender
race
sampl
sourc
symptom
underli
diseas
exact
test
use
test
associ
individu
virus
coinfect
urtilrti
first
sampl
test
posit
viru
use
purpos
first
episod
urti
lrti
use
analysi
whether
viru
isol
patient
urti
lrti
classifi
lrti
univari
logist
regress
analysi
perform
determin
associ
lrti
clinic
variabl
includ
age
continu
variabl
gender
race
anc
alc
use
steroid
week
infect
underli
diseas
versu
solid
tumor
versu
brain
tumor
versu
posthct
inpati
versu
outpati
statu
respiratori
virus
bacteri
pathogen
detect
factor
demonstr
statist
associ
p
includ
multipl
logist
regress
model
potenti
confound
assess
use
exact
test
durat
shed
analyz
descript
manner
report
pvalu
consid
signific
sa
version
sa
institut
cari
nc
statxact
cytel
corpor
cambridg
window
version
use
statist
analys
patient
ari
elig
enrol
studi
respiratori
viru
detect
patient
tabl
mean
age
median
rang
year
children
year
age
compris
three
quarter
patient
respiratori
viru
detect
common
underli
diagnosi
infect
patient
detect
respiratori
viru
significantli
differ
patient
solid
tumor
brain
tumor
posthct
p
hrv
common
respiratori
viru
detect
infect
patient
tabl
respiratori
virus
detect
patient
octob
march
patient
april
septemb
month
inclus
fig
patient
hrv
patient
hcov
infect
hrv
hcov
detect
patient
octobermarch
patient
respect
aprilseptemb
differ
distribut
statist
signific
hrv
p
hcov
p
hrv
piv
distribut
year
around
distribut
significantli
differ
among
group
patient
hrv
p
piv
p
patient
respiratori
viru
detect
urti
diagnos
lrti
patient
major
patient
urti
outpati
time
diagnosi
major
patient
lrti
inpati
time
diagnosi
symptom
urti
includ
rhinorrhea
cough
fever
patient
symptom
lrti
includ
cough
fever
short
breath
patient
abnorm
sign
lung
auscult
seen
patient
unilater
pulmonari
infiltr
seen
patient
bilater
interstiti
infiltr
peribronchi
thicken
remaind
radiographi
lrti
accompani
urti
patient
patient
sever
neutropenia
anc
cohort
develop
lrti
patient
sever
lymphopenia
alc
cell
develop
lrti
patient
sever
neutropenia
p
lymphopenia
p
increas
risk
develop
lrti
patient
respiratori
viru
detect
febril
patient
urti
lrti
febril
patient
underli
diagnosi
brain
tumor
solid
tumor
posthct
patient
lrti
patient
requir
oxygen
therapi
two
patient
admit
intens
care
unit
mechan
ventil
succumb
lrti
one
patient
acut
lymphoblast
leukemia
develop
infect
undergo
reducedintens
condit
allogen
hct
becam
tachypn
day
posthct
requir
mechan
ventil
die
day
respiratori
failur
patient
infant
acut
lymphoblast
leukemia
week
reinduct
admit
respiratori
distress
anc
alc
detect
rsv
therapi
institut
ribavirin
palivizumab
improv
sever
day
subsequ
respiratori
distress
worsen
requir
mechan
ventil
week
hospit
die
week
later
respiratori
failur
patient
coinfect
hrv
underli
diagnos
patient
lrti
solid
tumor
brain
tumor
respect
six
patient
underw
hct
patient
posthct
like
develop
lrti
compar
patient
malign
p
distribut
underli
virus
patient
differ
underli
diseas
shown
tabl
patient
solid
tumor
increas
risk
develop
lrti
hbov
p
hrv
p
respect
multipl
logist
regress
show
hbov
infect
commonli
detect
patient
lrti
p
tabl
patient
lrti
lrti
diagnos
mainten
phase
chemotherapi
induct
diagnosi
underli
diseas
patient
diagnos
solid
tumor
lrti
offtherapi
patient
underw
bronchoalveolar
lavag
posthct
other
diagnos
solid
tumor
respiratori
virus
detect
posthct
patient
hrv
hbov
piv
coinfect
least
addit
respiratori
viru
seen
infect
patient
significantli
higher
patient
lrti
p
tabl
patient
p
solid
tumor
p
posthct
p
patient
lrti
requir
oxygen
therapi
coinfect
viru
seen
patient
includ
patient
acut
lymphoblast
leukemia
coinfect
hrv
hbov
hmpv
c
pneumonia
detect
time
initi
present
respiratori
symptom
resolv
within
week
start
induct
therapi
leukemia
toler
well
without
respiratori
complic
patient
c
pneumonia
detect
lrti
one
patient
coinfect
hrv
lrti
resolv
patient
without
oxygen
therapi
pneumonia
detect
patient
three
coinfect
hrv
two
patient
hrv
coinfect
develop
lrti
resolv
without
complic
b
pertussi
detect
patient
bacteri
fungal
pathogen
detect
patient
lrti
patient
repeat
sampl
collect
base
persist
symptom
median
rang
sampl
collect
patient
median
durat
rang
viral
shed
patient
influenza
piv
rsv
hrv
day
respect
patient
shed
influenza
hrv
day
owe
small
number
comparison
could
made
patient
differ
underli
diseas
virus
hrv
common
viru
detect
patient
urti
lrti
prospect
studi
children
cancer
posthct
recent
hrv
note
associ
hospit
respiratori
ill
young
children
prospect
studi
use
molecular
method
milano
et
al
adult
allogen
hct
recipi
detect
hrv
patient
season
detect
median
durat
shed
rang
week
patient
lrti
hrv
show
season
pattern
detect
children
lrti
seri
progress
lrti
hrv
infect
note
immunocompet
children
year
age
associ
high
viral
load
retrospect
hospitalbas
studi
hcov
detect
use
molecular
method
children
children
infect
hcov
sole
pathogen
lrti
six
patient
immunocompromis
lrti
milano
et
al
detect
hcov
adult
hct
patient
case
common
winter
median
durat
shed
rang
week
patient
lrti
hcov
show
season
distribut
seen
lrti
children
seri
howev
preval
hcov
seri
significantli
higher
symptomat
immunocompet
children
compar
asymptomat
control
similarli
other
shown
similar
rate
detect
hbov
immunocompet
patient
pneumonia
coinfect
virus
compar
control
although
hbov
significantli
associ
pneumonia
requir
hospit
studi
coinfect
virus
common
patient
lrti
hbov
detect
seri
coinfect
virus
patient
requir
oxygen
therapi
resolv
without
complic
studi
assess
role
hbov
asymptomat
immunocompromis
control
need
role
hbov
respiratori
pathogen
present
remain
unclear
lethal
hmpv
infect
primarili
describ
adult
hematolog
malign
detect
patient
patient
lrti
die
due
hmpv
infect
patient
hmpv
lrti
studi
requir
oxygen
therapi
recov
without
complic
c
pneumonia
pneumonia
detect
infrequ
immunocompromis
children
seri
serolog
evid
chlamydi
infect
observ
patient
malign
lymphoma
patient
c
pneumonia
coinfect
seri
acut
lymphoblast
leukemia
mild
diseas
cours
one
patient
neutropen
sever
c
pneumonia
infect
previous
document
patient
acut
lymphoblast
leukemia
therapyrel
neutropenia
pneumonia
caus
agent
pneumonia
immunocompromis
host
describ
isol
case
report
infrequ
detect
pathogen
prospect
studi
novel
observ
may
implic
empir
therapi
patient
fever
pulmonari
infiltr
previous
report
increas
risk
lrti
respiratori
viru
infect
children
sever
neutropenia
lymphopenia
treatment
hematolog
malign
seen
present
studi
perhap
major
patient
neutropen
lymphopen
studi
ari
children
leukemia
focus
febril
patient
quarter
patient
studi
febril
henc
ari
may
underestim
febril
episod
studi
higher
incid
posit
test
respiratori
virus
lrti
seen
children
hematolog
malign
compar
immunocompet
control
studi
advantag
prospect
use
multiplex
molecular
diagnost
detect
newli
describ
respiratori
virus
uniqu
popul
healthi
asymptomat
patient
shed
hrv
hcov
henc
infer
causal
made
caution
symptomat
patient
receiv
oper
characterist
analysi
quantit
hrv
detect
shown
cutoff
valu
clinic
relev
symptomat
asymptomat
patient
feasibl
could
implic
infect
control
current
patient
symptom
ari
place
respiratori
isol
institut
furthermor
accur
diagnosi
hrv
infect
patient
may
futur
treatment
implic
antivir
pleconaril
inhibit
vitro
replic
rhinovirus
doubleblind
random
placebocontrol
trial
shown
earli
pleconaril
treatment
well
toler
led
signific
reduct
symptom
sever
frequenc
recoveri
hrv
within
day
initi
therapi
major
limit
studi
lack
asymptomat
immunocompromis
control
patient
diseas
subset
casecontrol
analysi
nasopharyng
wash
although
prefer
respiratori
sampl
collect
well
toler
children
due
unpleas
sensat
salin
nasopharynx
preclud
inclus
adequ
number
control
subject
casecontrol
comparison
furthermor
absenc
viral
load
data
sampl
base
presenc
symptom
ari
followup
patient
later
becam
asymptomat
number
repeat
sampl
per
patient
like
often
enough
captur
true
durat
shed
bronchoalveolar
lavag
perform
major
patient
lrti
copathogen
may
either
detect
overrepres
hrv
common
viru
detect
patient
cancer
cours
lrti
sever
major
patient
hrv
infect
shown
contribut
develop
invas
pneumococc
diseas
young
children
pcrbase
assay
detect
hrv
emerg
respiratori
virus
recent
becom
commerci
avail
may
valu
immunocompromis
children
multivir
infect
also
increasingli
recogn
use
newer
diagnost
method
shown
associ
lrti
larger
prospect
studi
viral
load
determin
need
studi
associ
emerg
respiratori
virus
lrti
children
cancer
posthct
